US Patent Issued to Certis Oncology Solutions on March 18 for "Artificial intelligence for identifying one or more predictive biomarkers" (California Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,254,987, issued on March 18, was assigned to Certis Oncology Solutions Inc. (San Diego).

"Artificial intelligence for identifying one or more predictive biomarkers" was invented by Long Hoang Do (Solana Beach, Calif.), Yuan Hung Chien (San Diego) and Peter Ellman (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and systems of using at least one hardware processor to train a machine learning algorithm to identify one or more predictive drug molecular features and/or predictive gene biomarkers for cancer treatment is provided. In some embodiments, the method uses at least one cancer drug discovery data set to train at least one learning ...